Avanos Medical Inc. Stock News

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

Confluence Investment Management LLC raised its position in Avanos Medical Inc (NYSE:AVNS) by 86.0% in the 1st quarter, Holdings Channel reports. The firm owned 606,007 shares of the company’s stock

Bank of New York Mellon Corp lowered its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 2.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Ex

Avanos Medical Inc (NYSE:AVNS) shares rose 8.3% during mid-day trading on Monday . The company traded as high as $26.22 and last traded at $25.74, approximately 387,360 shares changed hands during mid

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

Mason Street Advisors LLC boosted its holdings in Avanos Medical Inc (NYSE:AVNS) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned

Cubist Systematic Strategies LLC lifted its position in shares of Avanos Medical Inc (NYSE:AVNS) by 475.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchang

Axa grew its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 15.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,200 sh

Avanos Medical Inc (NYSE:AVNS) traded down 12.8% during trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $35.00 to $32.00. Stifel Nicolaus currently has a hold r

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Avanos Medical (AVNS) today and set a price target of $32.00. The company's shares closed

Amalgamated Bank boosted its holdings in Avanos Medical Inc (NYSE:AVNS) by 9.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Co

Avanos Medical (NYSE:AVNS) had its target price lowered by Morgan Stanley from $32.00 to $29.00 in a report published on Friday morning, AnalystRatings.com reports. The brokerage currently has a sell

Equities analysts expect Avanos Medical Inc (NYSE:AVNS) to post earnings of $0.17 per share for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for

In a report released today, David Lewis from Morgan Stanley maintained a Sell rating on Avanos Medical (AVNS), with a price target of $29.00. The